Real-World Effectiveness Analysis of Switching From Liraglutide or Dulaglutide to Semaglutide in Patients With Type 2 Diabetes Mellitus: The Retrospective REALISE-DM Study
figureposted on 2020-12-24, 11:04 authored by Adis journals on behalf of, Akshay B. Jain, Steve Kanters, Reena Khurana, Jagoda Kissock, Naomi Severin, Sara G. Stafford
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.